Portfolio
Corner Office
Culture
Premium
Opinion
Events
Research
Video
Innovation
Subscribe
Sign In
Register
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Events
Research
Video
Innovation
Subscribe
Sign In
Register
Search Query
Submit Search
Show Search
Actavis
Corner Office
Golden Parachutes Leave Investors Fearing Conflict of Interest
Jeff Ostrowski
May 17, 2016
Portfolio
Allergan-Pfizer Merger Gives Pharma a Growth Injection
Anne Szustek
December 16, 2015
Portfolio
Daily Agenda: Gravity Returns to Chinese Stock Market
Andrew Barber
July 27, 2015
Premium
Funds Benefit from Merger-Happy Health Care Stocks
Stephen Taub
June 23, 2015
Premium
Tiger Bloc’s Biggest Holdings: Actavis, CDK and JD.com
Stephen Taub
June 4, 2015
Portfolio
The Morning Brief: Snapchat on the Road to Raising $650 Million
Stephen Taub
June 1, 2015
Premium
Viking Global Breaks with Tiger Cubs and Bets on Health Care
Stephen Taub
April 30, 2015
Premium
Conatus Capital Raises Funds for Long-Only Fund
Stephen Taub
April 22, 2015
Premium
Lone Pine on the Double-Edged Sword of Low Rates
Stephen Taub
April 15, 2015
Portfolio
Actavis CEO Brent Saunders Has a Vision for Growth
Anne Szustek
March 12, 2015
Portfolio
Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions
Anne Szustek
December 10, 2014